Published in Thyroid on October 01, 2010
Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood (2004) 1.83
Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc Natl Acad Sci U S A (2007) 1.54
Insulin stimulates fibroblast proliferation through calcium-calmodulin-dependent kinase II. Cell Cycle (2009) 1.53
Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol (2010) 1.42
Radioiodide induces apoptosis in human thyroid tissue in culture. Endocrine (2013) 1.39
Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cells. Blood (2007) 1.37
The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. J Clin Endocrinol Metab (2011) 1.35
The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration. J Clin Invest (2010) 1.35
A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome. J Clin Endocrinol Metab (2012) 1.30
Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer (2004) 1.26
Acute presentation of spinal epidural cavernous angiomas: case report. Neurosurgery (2007) 1.24
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET. Clin Endocrinol (Oxf) (2013) 1.22
The cleavage of the urokinase receptor regulates its multiple functions. J Biol Chem (2002) 1.21
Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Clin Endocrinol (Oxf) (2007) 1.21
Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis. J Clin Endocrinol Metab (2006) 1.21
Anandamide inhibits adhesion and migration of breast cancer cells. Exp Cell Res (2005) 1.21
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways. Mol Cancer (2009) 1.20
Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation. J Biol Chem (2003) 1.19
Fine-needle cytology of Hürthle cell tumors and morphometry. Cancer Cytopathol (2014) 1.18
Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules? Thromb Haemost (2005) 1.16
Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. Prostate (2006) 1.12
Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review. BMC Surg (2013) 1.10
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint. Eur J Endocrinol (2011) 1.10
High diagnostic accuracy and interobserver reliability of real-time elastography in the evaluation of thyroid nodules. Ultrasound Med Biol (2012) 1.06
In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer. Cancer Res (2006) 1.04
β-Catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells. Gastroenterology (2012) 1.04
The different cardiac expression of the type 2 iodothyronine deiodinase gene between human and rat is related to the differential response of the Dio2 genes to Nkx-2.5 and GATA-4 transcription factors. Mol Endocrinol (2003) 1.02
Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness. Expert Opin Ther Targets (2013) 1.02
Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2. J Immunol (2004) 1.01
Fibronectin-induced proliferation in thyroid cells is mediated by alphavbeta3 integrin through Ras/Raf-1/MEK/ERK and calcium/CaMKII signals. J Clin Endocrinol Metab (2005) 1.00
High growth rate of benign thyroid nodules bearing RET/PTC rearrangements. J Clin Endocrinol Metab (2011) 1.00
Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application. Endocr J (2010) 0.98
Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA). Eur J Endocrinol (2006) 0.98
Primary lymphoma of the heart. A case report and review of the literature. Leuk Res (2002) 0.97
Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma. Thyroid (2013) 0.97
Hepatic arterial embolization in patients with neuroendocrine tumors. J Exp Clin Cancer Res (2014) 0.94
Fine-needle aspiration biopsy of the thyroid: comparison between thyroid palpation and ultrasonography. Endocr Pract (2002) 0.94
A novel NKX2.1 mutation in a family with hypothyroidism and benign hereditary chorea. Thyroid (2008) 0.94
Intratumor BRAFV600E heterogeneity and kinase inhibitors in the treatment of thyroid cancer: a call for participation. Thyroid (2013) 0.93
An unusual case of primary choriocarcinoma of the lung. BMC Surg (2013) 0.93
Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma. Endocr Relat Cancer (2007) 0.93
Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1. J Clin Endocrinol Metab (2003) 0.92
Unusual case of exacerbation of sub-acute descending necrotizing mediastinitis. BMC Surg (2013) 0.91
Calcium-calmodulin-dependent kinase II (CaMKII) mediates insulin-stimulated proliferation and glucose uptake. Cell Signal (2009) 0.91
Diagnostic utility of BRAFV600E mutation testing in thyroid nodules in elderly patients. BMC Surg (2013) 0.91
Transcription factor Nkx-2.5 induces sodium/iodide symporter gene expression and participates in retinoic acid- and lactation-induced transcription in mammary cells. Mol Cell Biol (2004) 0.90
Pulmonary sequestration presented as massive left hemothorax and associated with primary lung sarcoma. BMC Surg (2013) 0.90
The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor. Cell Mol Life Sci (2010) 0.90
Calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylates Raf-1 at serine 338 and mediates Ras-stimulated Raf-1 activation. Cell Cycle (2012) 0.89
Migration of surgical clips through a right lobectomy stump mimicking an asthmatic syndrome. BMC Surg (2013) 0.89
Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp. Chemotherapy (2004) 0.89